Mapping the Health Status of the Population of French Polynesia: the MATAEA Project

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1942 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-04

Study Completion Date

2021-12-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a cross-sectional study carried out on a sample of the adult population aged 18 to 69, distributed over the five archipelagos of French Polynesia.

Participation in the study involves: agreement to answer a questionnaire to collect information on socio-demographic characteristics, lifestyle habits and medical history; physical measurements (height, weight, waist circumference, blood pressure and skin pigmentation); and agreement to take biological samples (blood, saliva and stool) for biological, genetic and microbiological analyses.

The aim of the study is to assess the current health status of the population of French Polynesia and to evaluate the influence of contextual risk factors (lifestyle, place of residence, history of infection) and intrinsic susceptibility factors (genetics, age, gender, microbiota) in relation to non-communicable and infectious diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Baromètre Santé Adulte 2021-2022

NCT05218304

Diabetes Hypercholesterolemia Renal Failure +7 more

SUSPENDED NA

Risk Factors Associated With the Global Burden of Disease in Reunion Island and Comparison With Mainland France and Indian Ocean Countries

NCT03357302

Disability or Chronic Disease Leading to Disablement

COMPLETED

Evaluation of Report-Back Strategies for Long-term and Short-term Exposure Information in Rural Tribal Populations

NCT06593340

Behavior Change

NOT_YET_RECRUITING NA

Impact of COVID-19 on Marshallese Communities in the U.S.

NCT04474496

COVID-19

COMPLETED

Environmental Health Effects on Your Physiology

NCT03986814

Obesity

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non Communicable Diseases Microbiome Communicable Diseases Pesticide Exposure Metal Poison Genetics Population Ciguatera

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects representative of the adult population (18-69 y) of French Polynesia

Population sample composed of people aged 18 to 69. These people must have been living in French Polynesia for more than two years at the time of the 2017 census

Group Type EXPERIMENTAL

Questionnaire

Intervention Type OTHER

Questionnaire about socio-demographical status, health status and lifestyle habits

Physical measurements

Intervention Type OTHER

Measurement of height, weight, waist circumference, blood pressure and skin pigmentation

Biological samples

Intervention Type OTHER

Collect venous blood, saliva and stool samples

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Questionnaire about socio-demographical status, health status and lifestyle habits

Intervention Type OTHER

Physical measurements

Measurement of height, weight, waist circumference, blood pressure and skin pigmentation

Intervention Type OTHER

Biological samples

Collect venous blood, saliva and stool samples

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* be aged 18 or over and under 70 on the date of recruitment
* having signed the consent form

Exclusion Criteria

* Minors
* Pregnant or parturient women, and nursing mothers
* Persons deprived of their liberty by a judicial or administrative decision
* Adults who are the subject of a legal protection measure or who are unable to express their consent
* People undergoing psychiatric care
* Individuals who are not affiliated to a social security scheme or beneficiaries of such a scheme
* Homeless people
* Disabled people (unable to move)
* People unable to answer the questionnaire

Minimum Eligible Age

18 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes